Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Biotech
Gilead pays partner Hookipa $10M for HBV, HIV vaccines
Gilead is paying $10 million for sole ownership of arenaviral immunotherapies for hepatitis B and HIV.
James Waldron
May 22, 2025 10:10am
GSK posts data on HIV assets vying for roles in 6-month combo
Mar 12, 2025 11:25am
Immunocore bispecific reduces HIV reservoir in early trial
Mar 10, 2025 3:00pm
Merck's HIV combo treatment meets efficacy bar in phase 3 trials
Dec 19, 2024 11:54am
Jury convicts 2 former biopharma leaders of fraud
Dec 11, 2024 10:26am
Gilead buys HIV vaccine from biotech following clinical collab
Nov 25, 2024 10:30am
